Screening by Aurora Sample Clauses
Screening by Aurora. During the Collaboration Period, Aurora shall use each Screen validated pursuant to Section 2.2.2 to test the activity of Compounds provided by Allelix or agreed by the parties pursuant to Section 3.1.2. Aurora shall, with regard to each such Screen, screen Compounds as determined by the CC and provide retests of Compounds or putative Hits, and determination of crude IC50's as determined by the CC (the "Screening Program").
Screening by Aurora. During the Collaborative Period and for [***] thereafter, Senomyx may purchase from Aurora contract screening pursuant to Section 3.3. Aurora will screen Aurora Compounds or Senomyx Compounds as determined by the Steering Committee and provide re-tests of putative Hits, and determination of crude EC50s or IC50s as determined by the Steering Committee (an "Aurora Screening Program").
Screening by Aurora. During the Collaborative Period and for [...***...] thereafter, Senomyx may purchase from Aurora contract screening pursuant to Section 3.3. Aurora will screen Aurora Compounds or Senomyx Compounds as determined by the Steering Committee and provide re-tests of putative Hits, and determination of crude EC50s or IC50s as determined by the Steering Committee (an "Aurora Screening Program").
2.4.1 SENOMYX COMPOUNDS. Senomyx shall, [...***...], supply Aurora with Senomyx Compounds for each Aurora Screening Program. Any Senomyx Compounds supplied by Senomyx for use in an Aurora Screening Program will be [...***...], or another format mutually agreed to in writing by the parties (the "Compound Supply"). The quantities needed for each screen will be specified in writing in the Work Plan. Aurora agrees not to transfer the Compound Supply to any Third Party or to use it for any purpose other than developing or screening Assay Platforms without Senomyx's prior written consent. Aurora will return to Senomyx any unused Compound Supply.
2.4.2 AURORA COMPOUND SUPPLY. Aurora will make available to Senomyx [...***...] Aurora Compounds for use in Aurora Screening Programs. The Steering Committee will select, on an entire microtiter plate-by-entire microtiter plate basis, Aurora Compounds for use in an Aurora Screening Program. Information concerning Aurora Compounds shall be owned exclusively by Aurora and shall be treated as Confidential Information of Aurora hereunder.
Screening by Aurora. For the first *** Collaborative Screens validated, pursuant to Section 3.1.1.4, and thereafter up to *** collaborative screens per calendar year, Aurora will testthe activity of at least *** provided by PD or chemicals agreed to by the parties pursuant to Section 3.1.